Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer

NCT05152797 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Tumor Infiltrating Lymphocytes

Interventions

BIOLOGICAL: Autologous tumor-infiltrating lymphocytes

Sponsor

Women's Hospital School Of Medicine Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]